London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I must admit, if I was a new trader, I would be very concerned about the drop of Destiny's share price but I've seen it all before with Verona Pharma. I first bought some VRNA shares at 8p and saw the price go on a fairground ride before I eventually sold at £17.50. I remember many people demanding that the company put out a statement clarifying that the huge dips in share prices was not based on any foundation but Verona never bothered which did incense some of the traders however it came good in the end. All I watch in Dest8ny are the institutional holders and if they started jumping ship I would, but they all seem to have confidence in the company and these are big companies like Hargreaves Lansdown. Like everyone else, I've lost a lot on this drop but will just stop looking at the share price for a year and hopefully get a nice surprise in a year's time. In the immortal words of Corporal Jones 'don't panic'
ThunderRoad, I agree DEST is not a share for short term traders - time span between significant news is just too long for some and not enough feedback from the company. I believe the XF-73 deal will be announced 'soon' but I think its a complex deal which is why its taking a long time. I've been quietly adding at these ridiculously low levels (today's trades at about 25.3 - 25.4 are in fact BUYS, not SELLS, by the way), so one person's concern is another person's opportunity. Its a matter of being patient, focusing on the fundamentals and ignoring moronic BB chat and bloggers with their own agendas.
ThunderRoad and kipper, its not just Destiny. Look at all the other small caps. So many are showing outstanding value after price falls. Let's not forget that it is the end of the tax year and this is a time when investors adjust portfolios for tax purposes leading to selling for tax purposes. Perhaps this is also a factor for some small caps.
Kipper and Volmer, I agree with you both, in that patience is the key with this drug. I fail to understand why traders are still selling when the shares are 1/3 of the price from 3 weeks ago, there is no value in selling, even to pay a tax bill. I certainly won't be selling and when I feel the doomsters have all sold out, I will be filling my boots at this bargain price.
Although there is potential for a second phase 2 because of the restructuring of the drug, delaying it's commercialisation, that 2nd phase 2 as far as I know, still hasn't been confirmed yet meaning there could be an announcement round the corner confirming the start of phase3. . Even if there is a 2nd phase 2, it will only delay by 6 months and I'm happy to wait.
If you consider XF73 is 2-3 years away from being commercial, Steriwave could have become the standard of Care by that time.
Possibly but I thought XF-73 was more effective? Both have a fast bacterial mechanism of 10mins or so but Steriwave 50% effective, according to the video in the link, where as Xf-73 is claimed to be 99.5% effective in eradicating Staphylococcus.
Yes, but don't forget that JohnHenry is probably not a holder of DEST shares.
PA has all the hallmarks of a fund raise.
Can never say never of course but I prefer to go off the RNS that states “The Company is funded through to Q1 2025, allowing it to deliver on its current planned activities.”
Agreed however the recent change to the M3 protocol may have moved that funding into 2024
Surely they now need to put out a statement to say that talks are ongoing and that they see no reason why ...
With a Mkt Cap dipping below £20 M i bought a few
Or was the seller for many months cleared out today? capitulation
Wgumcd
You made reference to Steriwave being 50% effective, but the following extract from Edison states:
"In Q422, the company reported that its US Phase II nasal disinfection study met the primary endpoint of eliminating or significantly decreasing nasal Staphylococcus aureus in 86% of carriers. "
Here is the link to the article: https://www.edisongroup.com/research/steriwave-initiates-uk-pilot-study-with-nhs/32588/
Reserved,
Accepted the Eddison article gives them very similar rates of efficacy. I was simply referring to an article linked in the post earlier, in fairness it does say at 'least' 50% so may be old.... the quote is made at 2.19 min's in..........
https://ondinebio.com/solutions/steriwave-healthcare/
The drop today, after recent declines , is concerning but I still bought today, Let's see what happens on the 25th